Fora Capital, LLC Chemo Centryx, Inc. Transaction History

Fora Capital, LLC

  • $789 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $131,667 - $307,640
5,939 New
5,939 $307,000
Q3 2020

Nov 13, 2020
SELL
$46.35 - $61.69 $255,481 - $340,035
-5,512 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$38.58 - $65.07 $133,988 - $225,988
3,473 Added 170.33%
5,512 $317 Million
Q1 2020

May 15, 2020
BUY
$32.73 - $50.78 $66,736 - $103,540
2,039 New
2,039 $81,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email